10:11 AM EST - Theratechnologies Inc. : Announced two poster presentations at the 19th Annual American Conference for the Treatment of HIV (ACTHIV 2025), taking place May 1-3 in Chicago. Both presentations focus on issues surrounding excess visceral abdominal fat (EVAF), a common comorbidity in people with HIV (PWH). Theratechnologies Inc.
shares T.TH are trading down $0.03 at $4.01.